Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Ketamine in Severe Traumatic Brain Injury [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating ketamine for severe traumatic brain injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Traumatic Brain Injury, Traumatic Encephalopathy | EARLY_Phase 1 | Status: RECRUITING